12-48108249-A-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001354735.1(PFKM):c.205+55A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00187 in 1,537,112 control chromosomes in the GnomAD database, including 46 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0096 ( 28 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 18 hom. )
Consequence
PFKM
NM_001354735.1 intron
NM_001354735.1 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.39
Genes affected
PFKM (HGNC:8877): (phosphofructokinase, muscle) Three phosphofructokinase isozymes exist in humans: muscle, liver and platelet. These isozymes function as subunits of the mammalian tetramer phosphofructokinase, which catalyzes the phosphorylation of fructose-6-phosphate to fructose-1,6-bisphosphate. Tetramer composition varies depending on tissue type. This gene encodes the muscle-type isozyme. Mutations in this gene have been associated with glycogen storage disease type VII, also known as Tarui disease. Alternatively spliced transcript variants have been described.[provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 12-48108249-A-C is Benign according to our data. Variant chr12-48108249-A-C is described in ClinVar as [Likely_benign]. Clinvar id is 1201026.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00963 (1466/152302) while in subpopulation AFR AF= 0.0338 (1405/41548). AF 95% confidence interval is 0.0323. There are 28 homozygotes in gnomad4. There are 699 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 28 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PFKM | NM_001166686.2 | c.205+55A>C | intron_variant | ||||
PFKM | NM_001354735.1 | c.205+55A>C | intron_variant | ||||
PFKM | NM_001354736.1 | c.205+55A>C | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PFKM | ENST00000340802.12 | c.205+55A>C | intron_variant | 2 | |||||
PFKM | ENST00000546755.5 | c.205+55A>C | intron_variant | 4 | |||||
PFKM | ENST00000548288.5 | c.205+55A>C | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.00961 AC: 1462AN: 152184Hom.: 28 Cov.: 32
GnomAD3 genomes
AF:
AC:
1462
AN:
152184
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00102 AC: 1416AN: 1384810Hom.: 18 AF XY: 0.000872 AC XY: 601AN XY: 689072
GnomAD4 exome
AF:
AC:
1416
AN:
1384810
Hom.:
AF XY:
AC XY:
601
AN XY:
689072
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00963 AC: 1466AN: 152302Hom.: 28 Cov.: 32 AF XY: 0.00939 AC XY: 699AN XY: 74480
GnomAD4 genome
AF:
AC:
1466
AN:
152302
Hom.:
Cov.:
32
AF XY:
AC XY:
699
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 15, 2018 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at